Aleidy Martinez-Patricio
Puebla, PUE, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Recombinant Hc-TeTx modulates TrkA-related signaling and preserves cholinergic integrity in the nucleus basalis magnocellularis after Aβ(25-35) injury.
Journal: Neuroscience
Published: April 09, 2026
Elucidating the putative role of cannabigerol: a hypothesis-generating review of neuroinflammatory and neuroprotective mechanisms with implications for drug-resistant epilepsy.
Journal: Frontiers in pharmacology
Published: November 28, 2025
The role of probiotics, prebiotics, and postbiotics: cellular and molecular pathways activated on glial cells in Alzheimer's disease.
Journal: Frontiers in neuroscience
Published: March 22, 2025
Amyloid-β (25-35) induces the morphological alteration of dendritic spines and decreases NR2B and PSD-95 expression in the hippocampus.
Journal: Neuroscience letters
Published: August 15, 2022
Intrapallidal injection of cannabidiol or a selective GPR55 antagonist decreases motor asymmetry and improves fine motor skills in hemiparkinsonian rats.
Journal: Frontiers in pharmacology
Published: May 17, 2022
Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer's and Parkinson's Disease.
Journal: Frontiers in neuroscience
Published: February 01, 2022
The C-terminal domain of the heavy chain of tetanus toxin prevents the oxidative and nitrosative stress induced by acute toxicity of 1-methyl-4-phenylpyridinium, a rat model of Parkinson's disease.
Journal: Neuroscience research
Published: May 18, 2021
The Chronic Oral Administration of Clobenzorex or Amphetamine Decreases Motor Behavior and Induces Glial Activation in the Striatum Without Dopaminergic Degeneration.
Journal: Neurotoxicity research
Published: April 30, 2021
Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease.
Journal: Frontiers in pharmacology
Published: August 17, 2020
Disturbance of the Glutamate-Glutamine Cycle, Secondary to Hepatic Damage, Compromises Memory Function.
Journal: Frontiers in neuroscience
Published: July 01, 2020
The therapeutic potential of galectin-1 and galectin-3 in the treatment of neurodegenerative diseases.
Journal: Expert review of neurotherapeutics
Published: April 19, 2020
The Acute Activation of the CB1 Receptor in the Hippocampus Decreases Neurotoxicity and Prevents Spatial Memory Impairment in Rats Lesioned with β-Amyloid 25-35.
Journal: Neuroscience
Published: February 21, 2019
Last Updated: 09/26/2026